The content on this site is intended for healthcare professionals only
METNET: A phase II trial of metformin in patients with well differentiated neuro...
Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
31 Mar 2022
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour)
Prof Thierry De Baere - Institut Gustave Roussy, Paris, France
8 May 2019
Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine ...
Prof Sandip Patel - UC San Diego, San Diego, USA
15 Apr 2019
Umbralisib shows early promise for patients with marginal zone lymphoma
Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
11 Apr 2019
Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative diso...
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
13 Dec 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
21 May 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
26 Feb 2018
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
27 Sep 2017
Problems with survivorship care in Europe
Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
9 Sep 2017
Underprovision and inequality of specialised cancer care
Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Gree...
9 Sep 2017